[Secondary hypertension due to glomerulonephritis].
Azuma
T
T
Second Department of Medicine, Hokkaido University School of Medicine.
Nakagawa
S
S
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002908:Chronic Disease; D005921:Glomerulonephritis / Q000150:complications*; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers